UCLA researchers found that boosting p53 protein with navtemadlin helped T cells fight melanoma cancer cells longer, but dosing challenges remain.
Researchers at Roswell Park Comprehensive Cancer Center have identified a promising strategy for overcoming one of the ...
Flow Space on MSN
Biomarker Testing for Breast Cancer: How It Guides Treatment
Dr. Elizabeth Comen explains why managing side effects, speaking up about challenges and protecting your quality of life are ...
Eleventh annual fundraising effort brings Lendmark’s cumulative total to more than $12.4 million raised for pediatric cancer ...
By Dennis Thompson HealthDay ReporterMONDAY, Oct. 26, 2026 (HealthDay News) — Starting survivorship care for patients with ...
A headline about a "breakthrough cancer vaccine" is bound to raise a big question: Can it actually cure cancer? That's what many patients are wondering after Moderna and Merck announced promising ...
Learn how colon cancer treatment varies by stage, from surgery for early disease to chemotherapy, targeted therapy, and ...
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...
November is Lung Cancer Awareness Month, a crucial time to raise public consciousness about the leading cause of cancer death ...
Edex Live on MSN
AIIMS Rajkot launches Rs 39-crore radiation unit to bolster cancer treatment and medical research
Gujarat: JP Nadda inaugurates AIIMS Rajkot's Rs 39-crore cancer treatment facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results